Nehmat Houssami Selected Research

Ado-Trastuzumab Emtansine

8/2021

Trastuzumab emtansine for HER2-positive metastatic breast cancer: Outcomes from a whole-of-population Australian cohort.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nehmat Houssami Research Topics

Disease

38	Breast Neoplasms (Breast Cancer) 10/2021 - 03/2006
25	Neoplasms (Cancer) 03/2022 - 03/2006
9	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2021 - 02/2007
4	Neoplasm Metastasis (Metastasis) 03/2022 - 12/2014
3	Margins of Excision 11/2016 - 12/2010
2	Residual Neoplasm 10/2015 - 03/2013
2	Pathologic Complete Response 03/2013 - 12/2012
1	COVID-19 08/2020
1	Bone Diseases (Bone Disease) 01/2019
1	Second Primary Neoplasms (Neoplasms, Second) 12/2014
1	Arthralgia (Joint Pain) 06/2011
1	Endometrial Neoplasms (Endometrial Cancer) 06/2011
1	Premature Menopause 06/2011

Drug/Important Bio-Agent (IBA)

4	Trastuzumab (Herceptin)FDA Link 08/2018 - 01/2018
4	4-hydroxybenzylcyanideIBA 05/2013 - 12/2010
3	human ERBB2 proteinIBA 01/2019 - 01/2017
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2019 - 10/2018
2	Hormones (Hormone)IBA 01/2019 - 01/2019
2	Estrogen ReceptorsIBA 10/2018 - 08/2018
2	Biological ProductsIBA 01/2017 - 02/2007
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 12/2012
2	Tamoxifen FDA LinkGeneric 06/2011 - 03/2006
1	Ado-Trastuzumab EmtansineIBA 08/2021
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2019
1	Excipients (Suspending Agents)IBA 01/2019
1	insulin receptor-related receptor (IRR)IBA 02/2018
1	ORALIT (ORS)IBA 05/2013
1	Aromatase InhibitorsIBA 06/2011
1	Indicators and Reagents (Reagents)IBA 03/2006

Therapy/Procedure

20	Therapeutics 01/2021 - 03/2006
13	Segmental Mastectomy (Lumpectomy) 01/2021 - 09/2009
8	Mastectomy (Mammectomy) 01/2021 - 07/2008
6	Neoadjuvant Therapy 03/2022 - 12/2012
4	Radiotherapy 01/2019 - 09/2009
3	Hormone Replacement Therapy (Therapy, Hormone Replacement) 10/2021 - 06/2011
2	Operative Surgical Procedures 08/2020 - 05/2007
2	Lymph Node Excision (Lymph Node Dissection) 03/2014 - 06/2012
1	Precision Medicine 02/2020
1	Drug Therapy (Chemotherapy) 01/2019
1	Ambulatory Care (Outpatient Care) 01/2019
1	Immunotherapy 01/2019
1	Secondary Prevention 01/2019
1	Aftercare (After-Treatment) 03/2017
1	Terminal Care (Care, Terminal) 12/2014
1	Long-Term Care 06/2011